Top Biotechnology companies in the world by Price to Sales Ratio (P/S)

This ranking features the top 1,186 Biotechnology companies in the world ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 157,250.02, for January 15, 2025.

Global

Biotechnology

#	Name	Price to Sales Ratio (P/S)	Reported Date	Stock Price	Change	Country
1	Inhibikase Therapeutics, Inc. 1 IKT	184,503,984.00	Jan. 14, 2025	USD 2.66	NA	United States
2	Molecure S.A. 2 MOC.WA	1,481,732.57	Jan. 14, 2025	USD 2.23	1.07%	Poland
3	Genomtec S.A. 3 GMT.WA	91,280.05	Jan. 14, 2025	USD 1.74	1.31%	Poland
4	BrightPath Biotherapeutics Co., Ltd. 4 4594.T	48,782.23	Jan. 14, 2025	USD 0.27	-4.62%	Japan
5	NanoGroup S.A. 5 NNG.WA	43,209.58	Jan. 14, 2025	USD 0.79	1.05%	Poland
6	Benitec Biopharma Inc. 6 BNTC	40,164.37	Jan. 14, 2025	USD 10.38	-0.10%	United States
7	Greenwich LifeSciences, Inc. 7 GLSI	29,258.97	Jan. 14, 2025	USD 12.06	-1.63%	United States
8	OncoZenge AB (publ) 8 ONCOZ.ST	17,623.20	Jan. 14, 2025	USD 0.45	23.08%	Sweden
9	Forte Biosciences, Inc. 9 FBRX	15,578.39	Jan. 14, 2025	USD 14.62	-8.62%	United States
10	Diamyd Medical AB (publ) 10 DMYD-B.ST	13,325.69	Jan. 14, 2025	USD 1.61	0.34%	Sweden
11	Immix Biopharma, Inc. 11 IMMX	11,499.83	Jan. 14, 2025	USD 2.00	-5.66%	United States
12	Diamond Biofund Inc. 12 6901.TW	10,657.89	Jan. 14, 2025	USD 0.92	1.12%
13	Bullfrog AI Holdings, Inc. Common Stock 13 BFRG	10,613.47	Jan. 14, 2025	USD 2.10	-0.47%	United States
14	Cadrenal Therapeutics, Inc. Common Stock 14 CVKD	10,296.97	Jan. 14, 2025	USD 15.99	NA	United States
15	Revolution Medicines, Inc. 15 RVMD	9,919.66	Jan. 14, 2025	USD 39.83	-6.44%	United States
16	Allogene Therapeutics, Inc. 16 ALLO	9,362.10	Jan. 14, 2025	USD 1.92	-1.54%	United States
17	Viking Therapeutics, Inc. 17 VKTX	8,672.07	Jan. 14, 2025	USD 33.93	-12.73%	United States
18	Altimmune, Inc. 18 ALT	8,521.27	Jan. 14, 2025	USD 6.23	-8.11%	United States
19	Infant Bacterial Therapeutics AB (publ) 19 IBT-B.ST	7,217.70	Jan. 14, 2025	USD 4.07	-5.72%	Sweden
20	FunPep Company Limited 20 4881.T	6,112.67	Jan. 14, 2025	USD 0.87	-0.91%	Japan
21	Akero Therapeutics, Inc. 21 AKRO	5,375.03	Jan. 14, 2025	USD 21.87	-3.36%	United States
22	Lipum AB (publ) 22 LIPUM.ST	4,733.10	Jan. 14, 2025	USD 1.17	-3.73%	Sweden
23	Rezolute, Inc. 23 RZLT	4,715.37	Jan. 14, 2025	USD 4.72	-0.63%	United States
24	ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 24 1541.HK	4,673.89	Jan. 14, 2025	USD 0.62	4.32%	China
25	Viridian Therapeutics, Inc. 25 VRDN	4,422.27	Jan. 14, 2025	USD 16.86	-5.12%	United States
26	Carbios SAS 26 ALCRB.PA	4,085.55	Jan. 14, 2025	USD 6.44	-3.56%	France
27	Context Therapeutics Inc. 27 CNTX	3,918.10	Jan. 14, 2025	USD 0.99	-3.87%	United States
28	Checkpoint Therapeutics, Inc. 28 CKPT	3,293.60	Jan. 14, 2025	USD 3.17	-0.94%	United States
29	Crinetics Pharmaceuticals, Inc. 29 CRNX	3,179.32	Jan. 14, 2025	USD 35.62	-8.62%	United States
30	89bio, Inc. 30 ETNB	3,155.62	Jan. 14, 2025	USD 6.28	-0.47%	United States
31	INmune Bio, Inc. 31 INMB	3,143.74	Jan. 14, 2025	USD 5.96	-8.87%	United States
32	Sera Prognostics, Inc. 32 SERA	2,288.63	Jan. 14, 2025	USD 6.37	0.63%	United States
33	Enliven Therapeutics, Inc. 33 ELVN	2,271.95	Jan. 14, 2025	USD 20.46	-7.29%	United States
34	Immunovant, Inc. 34 IMVT	2,238.96	Jan. 14, 2025	USD 22.88	0.57%	United States
35	Quince Therapeutics, Inc. 35 QNCX	2,090.08	Jan. 14, 2025	USD 1.71	-1.16%	United States
36	Trevi Therapeutics, Inc. 36 TRVI	1,995.50	Jan. 14, 2025	USD 3.93	-1.50%	United States
37	Chimerix, Inc. 37 CMRX	1,906.98	Jan. 14, 2025	USD 3.37	1.81%	United States
38	Celcuity Inc. 38 CELC	1,702.50	Jan. 14, 2025	USD 10.53	-2.95%	United States
39	Cytokinetics, Incorporated 39 CYTK	1,658.21	Jan. 14, 2025	USD 45.23	-3.17%	United States
40	Tyra Biosciences, Inc. 40 TYRA	1,606.80	Jan. 14, 2025	USD 15.94	5.56%	United States
41	Corvus Pharmaceuticals, Inc. 41 CRVS	1,332.16	Jan. 14, 2025	USD 5.10	-1.92%	United States
42	Acelyrin, Inc. 42 SLRN	1,269.18	Jan. 14, 2025	USD 2.10	-2.33%	United States
43	Prestige BioPharma Limited 43 950210.KS	1,238.05	Jan. 14, 2025	USD 10.29	0.14%	Singapore
44	Spyre Therapeutics, Inc. 44 SYRE	1,203.69	Jan. 14, 2025	USD 20.80	-3.48%	United States
45	Edgewise Therapeutics, Inc. 45 EWTX	1,157.12	Jan. 14, 2025	USD 27.52	8.65%	United States
46	Structure Therapeutics Inc. 46 GPCR	1,092.72	Jan. 14, 2025	USD 25.38	0.87%	United States
47	Alzinova AB (publ) 47 ALZ.ST	983.80	Jan. 14, 2025	USD 0.29	0.68%	Sweden
48	BerGenBio ASA 48 BGBIO.OL	867.57	Jan. 14, 2025	USD 0.77	-0.80%	Norway
49	FluoGuide A/S 49 FLUO.ST	865.40	Jan. 14, 2025	USD 3.98	0.01%	Denmark
50	Gain Therapeutics, Inc. 50 GANX	851.42	Jan. 14, 2025	USD 2.08	-5.02%	United States

1 2 3 4 … 24

Frequently Asked Questions

Which Biotechnology company has the highest Price to Sales Ratio (P/S) ?

The Biotechnology company with the highest Price to Sales Ratio (P/S) is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at 184,503,984.00.
Which Biotechnology company has the lowest Price to Sales Ratio (P/S) ?

The Biotechnology company with the lowest Price to Sales Ratio (P/S) is Lipella Pharmaceuticals Inc. (NasdaqCM: LIPO) at 0.03.

What are the top 10 Biotechnology companies by Price to Sales Ratio (P/S) ?

The top 10 Biotechnology companies the Global by Price to Sales Ratio (P/S) are Inhibikase Therapeutics, Inc., Molecure S.A., Genomtec S.A., BrightPath Biotherapeutics Co., Ltd., NanoGroup S.A., Benitec Biopharma Inc., Greenwich LifeSciences, Inc., OncoZenge AB (publ), Forte Biosciences, Inc. and Diamyd Medical AB (publ).
What are the bottom 10 Biotechnology companies by Price to Sales Ratio (P/S) ?

The bottom 10 Biotechnology companies by Price to Sales Ratio (P/S) are Lipella Pharmaceuticals Inc., EASY HOLDINGS Co., Ltd., Benson Hill, Inc., Daesang Holdings Co., Ltd., SK Discovery Co., Ltd., Ildong Holdings Co., Ltd., Radius Health, Inc., Danimer Scientific, Inc., 22nd Century Group, Inc. and TS Corporation.